best performing mid cap stock may 2022 to july 2022

Belite Bio Inc ADR (BLTE) had the highest return between May 1, 2022 and July 31, 2022 by a mid-cap US stock, returning 265.6%.

ASSET DATE % RETURN
Belite Bio Inc ADR (BLTE)
5/1/2022 - 7/31/2022
265.61%
Pagaya Technologies (PGY)
5/1/2022 - 7/31/2022
151.72%
New Oriental Education & Technology (EDU)
5/1/2022 - 7/31/2022
114.14%
Rhythm Pharmaceuticals (RYTM)
5/1/2022 - 7/31/2022
103.23%
Quantum Computing  (QUBT)
5/1/2022 - 7/31/2022
99.35%
Arcellx (ACLX)
5/1/2022 - 7/31/2022
93.38%
TransMedics (TMDX)
5/1/2022 - 7/31/2022
91.74%
Enphase Energy (ENPH)
5/1/2022 - 7/31/2022
78.31%
Cogent Biosciences (COGT)
5/1/2022 - 7/31/2022
74.92%
Impinj (PI)
5/1/2022 - 7/31/2022
73.16%
Uniqure (QURE)
5/1/2022 - 7/31/2022
69.23%
Beam Therapeutics  (BEAM)
5/1/2022 - 7/31/2022
68.49%
Privia Health (PRVA)
5/1/2022 - 7/31/2022
67.87%
Modine Manufacturing (MOD)
5/1/2022 - 7/31/2022
66.5%
Torm PLC Class A (TRMD)
5/1/2022 - 7/31/2022
65.05%
89bio (ETNB)
5/1/2022 - 7/31/2022
63.59%
Griffon (GFF)
5/1/2022 - 7/31/2022
63.25%
Sunrun (RUN)
5/1/2022 - 7/31/2022
63.12%
Ideaya Biosciences (IDYA)
5/1/2022 - 7/31/2022
56.23%
Scorpio Tankers (STNG)
5/1/2022 - 7/31/2022
56.03%
H&R Block (HRB)
5/1/2022 - 7/31/2022
53.97%
Alignment Healthcare LLC (ALHC)
5/1/2022 - 7/31/2022
53.4%
Eos Energy Enterprises (EOSE)
5/1/2022 - 7/31/2022
51.67%
Crispr Therapeutics (CRSP)
5/1/2022 - 7/31/2022
51.27%
CommScope (COMM)
5/1/2022 - 7/31/2022
50.75%
Mid-cap stocks are treated as having a market cap between $2B and $10B.